Prognostic role of the neutrophil–lymphocyte ratio in renal cell carcinoma: a meta-analysis
Authors:
Open Access
Abstract
Objective Increasing evidence suggests that cancer-associated inflammation is associated with poor prognosis in patients with cancer. The role of the neutrophil–lymphocyte ratio (NLR) as a predictor in renal cell carcinoma (RCC) remains controversial. We conducted the meta-analysis to determine the association between NLR and clinical outcome of patients with RCC. Methods and materials Studies were identified from PubMed and EMBASE databases in March 2014. Meta-analysis was performed to generate combined HRs with 95% CIs for overall survival (OS) and recurrence-free/progress-free survival (RFS/PFS). Results 15 cohorts containing 3357 patients were included. Our analysis results indicated that elevated NLR predicted poorer OS (HR=1.82, 95% CI 1.51 to 2.19) and RFS/PFS (HR=2.18, 95% CI 1.75 to 2.71) in patients with RCC. These findings were robust when stratified by study region, sample size, therapeutic intervention, types of RCC and study quality. However, it differed significantly by assessment of the cut-off value defining ‘elevated NLR’ in RFS/PFS (p=0.004). The heterogeneity in our meta-analysis was mild to moderate. Conclusions Elevated NLR indicates a poorer prognosis for patients with RCC. NLR should be monitored in patients with RCC for rational risk stratification and treatment individualisation.Keywords
This publication has 40 references indexed in Scilit:
- External validation of the modified Glasgow prognostic score for renal cancerIndian Journal of Urology, 2014
- The Protease Activated Receptor 1 Gene Variation IVSn –14 A>T is Associated with Distant Metastasis and Cancer Specific Survival in Renal Cell CarcinomaJournal of Urology, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance statusInternational Journal of Clinical Oncology, 2013
- Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systemsBritish Journal of Cancer, 2011
- A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome StudyEuropean Journal of Cancer, 2011
- Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive proteinBritish Journal of Cancer, 2010
- Epidemiology and risk factors for kidney cancerNature Reviews Urology, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Role of Systemic Inflammatory Response in Predicting Survival in Patients with Primary Operable CancerFuture Oncology, 2009